Results 201 to 210 of about 1,422,405 (264)

Astrocyte heterogeneity in brain metastases

Molecular Oncology, EarlyView.
Astrocytes emerge as pivotal regulators of metastatic colonization, survival, immune remodeling, and therapy response associated with an increasing heterogeneity that requires spatially and longitudinally resolved approaches to uncover regulatory programs and guide context‐specific therapies.
Carolina Hernández‐Oliver, Neibla Priego, Manuel Valiente   +2 more
wiley   +1 more source

Differential associations between early life adversity subtypes and adolescent stress reactivity across neuroendocrine, autonomic, immune, and metabolic systems. [PDF]

Neurobiol Stress
Kuhlman KR, Pugh AJ, Rodgers EL.
europepmc   +1 more source

Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1. [PDF]

Neoplasia
Takeuchi S, Kobayashi M, Lee PWT, Takahashi I, Yoshihara T, Harada H.   +5 more
europepmc   +1 more source

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

Molecular Oncology, EarlyView.
Primary brain tumors, whether in adults or children, present a major challenge because of their dramatic prognosis and the ongoing lack of efficient therapeutic approaches. In recent years, a shift has occurred from tumor‐centric concepts to a more holistic view of these tumors as dynamic ecosystems.
Julie Gavard, Flavie Bénard, Eva Billat, Margaux Le Guyon, Victoria Maltret, Laura Merlet, Chloé Astrid Walter, Tony Avril, Eric Chevet   +8 more
wiley   +1 more source

CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. [PDF]

Mol Biol Rep
Yi Lin Lee MC, Camargo JA, Caetano Vilas Boas G, Silva KS, Silva LP, Mioshi CM, Pimenta R, Silva IA, Ramos Moreira Leite K, Nahas WC, Dos Reis ST.   +10 more
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

A context-aware interpretive framework for lymphocyte immunophenotyping by flow cytometry. [PDF]

Front Immunol
Villegas-Valverde CA, Ventura-Carmenate Y.   +1 more
europepmc   +1 more source

Interaction of NDRG1 and TGM2 Modulates DNA Replication and Repair. [PDF]

Mol Cancer Res
Doh HM, Kozlova N, Cruz KA, Muranen T.
europepmc   +1 more source

Ion-coupled transfersome complexes for enhanced transdermal NAD⁺ repletion and mitigation of cellular senescence signatures. [PDF]

Mater Today Bio
Kang S, Wei S, Koo BI, Jo Y, Park J, Xue Y, Ye S, Park J, Hwang BW, Kim JH, Jeong E, Kim J, Kang NG, Jun SH, Ryu D.   +14 more
europepmc   +1 more source

Early Osteogenic and Stromal Marker Responses of Osteoblast-like and Bone-Marrow Stromal Cell Lines to a Hyaluronic Acid-Coated Xenogeneic Bone Graft: An Exploratory In Vitro Analysis. [PDF]

Dent J (Basel)
Mayer Y, Abu Sada H, Zigdon Giladi H, Gabay E, Doppelt-Flikshtain O, Ginesin O.   +5 more
europepmc   +1 more source